COMMUNIQUÉS West-GlobeNewswire

Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States

30/01/2018 - 22:47

HOUSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]

Avinger Announces Reverse Stock Split

30/01/2018 - 22:45

REDWOOD CITY, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will effect a 1- [...]

Vistin Pharma ASA : Vistin Pharma to postpone the expansion of the metformin production capacity

30/01/2018 - 22:38

Oslo, Norway, 30 January 2018 Norwegian pharmaceutical company Vistin Pharma ASA announced today that it has decided to postpone the construction of the new NOK 120 million production line at the Company's dedicated [...]

Vical Announces Restructuring to Focus Resources on HSV-2 and Antifungal Clinical Programs

30/01/2018 - 22:15

SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced a restructuring to conserve capital and to focus its efforts on VL-2397, its antifungal drug product candidate which is [...]

Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option

30/01/2018 - 22:05

CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) (the “Company” or “SLDB”), announced today the closing of its initial public offering of 8,984,375 shares of its common stock, [...]

Advanced Biomedical Technologies Inc. Granted New Patent Strengthening its Core Technology

30/01/2018 - 22:03

SHENZHEN, CHINA and NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Advanced Biomedical Technologies Inc. (OTCQB:ABMT), a developer and manufacturer of orthopaedic internal fixation devices, today announced the State [...]

AveXis to Initiate Screening for Remaining Patients in Pivotal Trial of AVXS-101 for SMA Type 1 Following Review of Preliminary Data from First Three Patients

30/01/2018 - 22:01

CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

30/01/2018 - 22:01

BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]

Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility

30/01/2018 - 22:01

SANTA BARBARA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for [...]

FOR IMMEDIATE RELEASE: The importance of mental health literacy among all of the awareness

30/01/2018 - 21:20

HALIFAX, Nova Scotia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Today our media feeds will be filled with support for mental illness and it will feel like awareness is high, but awareness alone is not enough. “While mental [...]

Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition

30/01/2018 - 20:13

Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. Department of Health and Human Services’ latest Request for Information on Promoting Health Care Choice and Competition Across the United [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2017

30/01/2018 - 18:01

Communiqué de presse Villepinte, le 30 janvier 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Invitation to Idorsia's full year results 2017 webcast and conference call

30/01/2018 - 17:40

Idorsia will publish its full year financial results 2017 on Tuesday 6 February 2018 at 07:00 CET. An investor conference call and webcast will be held to discuss the results on the same day at 14:00 CET / 13:00 GMT / [...]

CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion

30/01/2018 - 17:30

RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) please note that the stock symbol for Monster Digital, Inc [...]

Vaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s Disease

30/01/2018 - 17:14

ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other [...]

Local Volunteers Join America’s Toothfairy Smile Drive to Collect Oral Care Products for Royal Oak’s Teen Clean Closet

30/01/2018 - 16:45

ROYAL OAK, Mich., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Designed to raise awareness of the importance of oral health and collect oral care products for underserved children, the America’s ToothFairy Smile Drive is being [...]

Typenex® Medical Launches new line of Holmium Laser Fibers

30/01/2018 - 16:36

CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Typenex Medical , an industry leader in medical devices and supplies, today, announced it has launched Fibernex TM , a line of single-use and reusable holmium laser fibers [...]

Achaogen Announces Upgraded Status for Plazomicin Fill Manufacturer

30/01/2018 - 16:07

-- McPherson, Kansas facility compliance status amended to Voluntary Action Indicated (VAI) -- -- VAI status provides a clear regulatory path for potential approval of plazomicin out of McPherson facility -- SOUTH SAN [...]

Release date of annual report 2017 and audio cast

30/01/2018 - 15:54

Copenhagen, 2018-01-30 15:54 CET (GLOBE NEWSWIRE) -- On Tuesday, 6 February 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its annual report for 2017. ALK will host a meeting for analysts and institutional [...]